Skip to main content
Premium Trial:

Request an Annual Quote

Two Blades Licenses TAL Code Technology to Dupont Pioneer

NEW YORK (GenomeWeb News) – The Two Blades Foundation today announced a licensing agreement with Dupont Pioneer providing it access to 2Blades' TAL Code technology for commercial use in certain crop plants.

The licensed technology enhances Dupont Pioneer's ability to further develop advanced plant genetics, the foundation said. In return, Dupont Pioneer will provide 2Blades access to improvements it makes to the TAL Code technology for use in 2Blades' humanitarian efforts to support sustainable farming.

Financial and other terms of the agreement were not disclosed.

The TAL Code technology was discovered by researchers at Martin-Luther University in Halle, Germany and is based on novel sequence-specific DNA binding proteins that may be designed for the recognition of almost any sequence of interest. The Two Blades Foundation has exclusive rights for commercial use of the technology in plants and has licensed it to a number of partners, including most recently Monsanto and KWS SAAT.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.